Page last updated: 2024-08-24

zanamivir and Infections, Respiratory

zanamivir has been researched along with Infections, Respiratory in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	4 (66.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ariza-Heredia, EJ; Chemaly, RF; Shahani, L	1
Schmidt, RE	1
Bauer, TT; Rohde, G; Schultze-Werninghaus, G	1
Le Moing, V	1
Elliott, M; Hammond, JM; Hayden, FG; Kaiser, L; Keene, ON	1
Hayden, FG	1

Reviews

4 review(s) available for zanamivir and Infections, Respiratory

Article	Year
Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert review of anti-infective therapy, 2017, Volume: 15, Issue:4 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Coronavirus Infections; Cyclopentanes; Guanidines; Humans; Immunocompromised Host; Influenza, Human; Oseltamivir; Palivizumab; Paramyxoviridae Infections; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Zanamivir	2017
[Treatment for viral respiratory infections: Principles of action, strategies, and future prospects]. Der Internist, 2004, Volume: 45, Issue:4 Topics: Antiviral Agents; Guanidines; Humans; Influenza, Human; Neuraminidase; Practice Patterns, Physicians'; Pyrans; Respiratory Tract Infections; Sialic Acids; Treatment Outcome; Virus Diseases; Zanamivir	2004
Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults. Archives of internal medicine, 2000, Nov-27, Volume: 160, Issue:21 Topics: Acute Disease; Administration, Inhalation; Administration, Intranasal; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Double-Blind Method; Drug Prescriptions; Guanidines; Humans; Incidence; Influenza, Human; Middle Aged; Multicenter Studies as Topic; Pyrans; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Risk Factors; Sialic Acids; Time Factors; Treatment Outcome; Zanamivir	2000
Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention. Vaccine, 2000, Dec-08, Volume: 19 Suppl 1 Topics: Acetamides; Adult; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Eustachian Tube; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza, Human; Interferon-beta; Oseltamivir; Otitis Media; Otitis Media with Effusion; Picornaviridae Infections; Piperidines; Pressure; Pyrans; Pyridazines; Respiratory Tract Infections; Rhinovirus; Rimantadine; Sialic Acids; Superinfection; Virus Replication; Zanamivir	2000

Trials

1 trial(s) available for zanamivir and Infections, Respiratory

Article	Year
Drug under test: influenza--Relenza in daily practice. Experience during the influenza season 1999/2000. Medical microbiology and immunology, 2002, Volume: 191, Issue:3-4 Topics: Antiviral Agents; Drug Tolerance; Fever; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Pharyngitis; Pyrans; Respiratory Tract Infections; Risk; Seasons; Sialic Acids; Treatment Outcome; Zanamivir	2002

Article

Year

Drug under test: influenza--Relenza in daily practice. Experience during the influenza season 1999/2000.

Medical microbiology and immunology, 2002, Volume: 191, Issue:3-4

Topics: Antiviral Agents; Drug Tolerance; Fever; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Pharyngitis; Pyrans; Respiratory Tract Infections; Risk; Seasons; Sialic Acids; Treatment Outcome; Zanamivir

2002

Other Studies

1 other study(ies) available for zanamivir and Infections, Respiratory

Article	Year
[New antivirals for respiratory tract viruses]. Presse medicale (Paris, France : 1983), 1999, Nov-27, Volume: 28 Suppl 3 Topics: Antiviral Agents; Drug Approval; France; Guanidines; Humans; Influenza, Human; Neuraminidase; Oxadiazoles; Oxazoles; Picornaviridae Infections; Pyrans; Respiratory Tract Infections; Sialic Acids; Zanamivir	1999